Min-Chul Park
Direktor/Vorstandsmitglied bei ZYVERSA THERAPEUTICS, INC.
Vermögen: - $ am 30.06.2024
Ursprung des Netzwerks ersten Grades von Min-Chul Park
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 10 | |
ZyVersa Therapeutics Operating, Inc.
 ZyVersa Therapeutics Operating, Inc. Pharmaceuticals: MajorHealth Technology ZyVersa Therapeutics Operating, Inc. operates as a specialty pharmaceutical company, which develops and commercializes prescription pharmaceutical products. The firm focuses on developing products for the treatment of men?s health, as well as for other markets where current therapies are suboptimal and underdeveloped. It offers VAR 100, an oral formulation of native testosterone to treat male hypogonadism; and VAR 200 that minimizes and prevents kidney cell damage, and improves focal segmental glomerulosclerosis prognosis. The company was founded by Stephen C. Glover and Shawn M. Titcomb in 2014 and is headquartered in Weston, FL.
2
| Subsidiary | Pharmaceuticals: Major | 2 |
Inje University
2
| College/University | Other Consumer Services | 2 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Min-Chul Park
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| ABBOTT LABORATORIES | Medical Specialties | Corporate Officer/Principal | |
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Sales & Marketing Corporate Officer/Principal | |
Noven Pharmaceuticals, Inc.
 Noven Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Noven Pharmaceuticals, Inc. operates as a pharmaceutical company with transdermal expertise. It specializes in the research and development, manufacture, marketing, and sale of prescription pharmaceutical products. The company was founded in 1987 and is headquartered in Miami, FL. | Pharmaceuticals: Major | Sales & Marketing | |
| RESPIRERX PHARMACEUTICALS INC. | Pharmaceuticals: Major | Director/Board Member | |
| INSMED INCORPORATED | Pharmaceuticals: Major | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| H. LUNDBECK A/S | Pharmaceuticals: Major | Corporate Officer/Principal | |
| AUXILIUM PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Sales & Marketing | |
MAKO Surgical Corp.
 MAKO Surgical Corp. Medical SpecialtiesHealth Technology MAKO Surgical Corp. is a medical device company, which develops and markets advanced robotic arm solution, joint specific applications for the knee, hip and orthopedic implants for orthopedic procedures. It also provides RIO robotic arm interactive orthopedic system, including a tactile robotic arm utilizing an integrated bone cutting instrument and a patient specific visualization component. The company was founded by Maurice R. Ferre and Rony A. Abovitz in November 2004 and is headquartered in Fort Lauderdale, FL. | Medical Specialties | Corporate Officer/Principal | |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member | |
PDS Operating Corp.
 PDS Operating Corp. BiotechnologyHealth Technology PDS Operating Corp. operates as a biopharmaceutical company. It develops immunotherapies for cancer and infectious disease. The firm’s versamune is capable of potent activation of immune cells without the side effects of traditional vaccines, efficiently delivering disease related antigen targets to the immune system and promoting antigen processing to present antigen appropriately to generate both strong prophylactic and therapeutic immune responses to disease. The company was founded by Frank K. Bedu-Addo and Gregory L. Conn and is headquartered in Princeton, NJ. | Biotechnology | Director/Board Member | |
| RENOVARO INC. | Biotechnology | Director/Board Member | |
| PROBILITY MEDIA CORPORATION | Miscellaneous Commercial Services | Director/Board Member | |
| HEPION PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Executive Officer | |
PharmaNet, Inc.
 PharmaNet, Inc. Medical DistributorsDistribution Services PharmaNet, Inc. researches and develops new drugs and provides clinical development & consulting services. Its services include strategic planning, data management, bio-statistics, site management, study monitoring, protocol/CRF design, project management, information technology, quality control and assurance and regulatory affairs. The company was founded in 1996 by Jeffrey P. McMullen and is headquartered in Princeton, NJ. | Medical Distributors | General Counsel Corporate Officer/Principal | |
Bristol-Myers Squibb Holdings Ltd.
 Bristol-Myers Squibb Holdings Ltd. MiscellaneousMiscellaneous Part of Bristol Myers Squibb Co., Bristol-Myers Squibb Holdings Ltd. is a holding British company. The company is based in Uxbridge, UK. | Miscellaneous | Corporate Officer/Principal | |
| Rutgers State University of New Jersey | College/University | Undergraduate Degree | |
| Georgia Institute of Technology | College/University | Doctorate Degree | |
| Jones International University | College/University | Masters Business Admin | |
University of Miami
 University of Miami Other Consumer ServicesConsumer Services University of Miami (Florida) is a private research university with students from around the world that is focused on teaching and learning, the discovery of new knowledge, and service to the South Florida region and beyond. The university was founded in 1925 and it is headquartered in Coral Gables, FL. | College/University | Undergraduate Degree Undergraduate Degree | |
| BK TOPS CO., LTD. | Information Technology Services | Director/Board Member | |
| AMBRX INC | Pharmaceuticals: Major | Chairman Chief Executive Officer Chairman | |
EMD Serono, Inc.
 EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | Pharmaceuticals: Major | Corporate Officer/Principal Sales & Marketing | |
| NANOVIRICIDES, INC. | Pharmaceuticals: Major | Director/Board Member | |
Speedel Pharma AG
 Speedel Pharma AG Pharmaceuticals: MajorHealth Technology Speedel Pharma AG develops drugs for the treatment of cardiovascular and metabolic diseases. It researches on Renin Inhibitors and also develops an Endothelin Receptor Anatagonist. The company also operates in the U.S. and Japan. It was founded in 1998 and is headquartered in Basel, Switzerland. | Pharmaceuticals: Major | General Counsel | |
| Seoul National University | College/University | Undergraduate Degree | |
| Pusan National University | College/University | Doctorate Degree | |
| Philipps University of Marburg | College/University | Doctorate Degree | |
| OSSTEM IMPLANT CO., LTD. | Medical Specialties | Director/Board Member | |
BioNJ, Inc.
 BioNJ, Inc. Miscellaneous Commercial ServicesCommercial Services BioNJ, Inc. is based in Trenton, NJ. BioNJ, Inc. is a life sciences trade association with nearly 400 member companies. The company supports the discovery, development, and commercialization of therapies and cures that save and improve lives. BioNJ drives capital formation, fosters entrepreneurship, advocates for medical innovation, provides access to talent and education, and offers critical commercial resources. The company also serves as a clearinghouse for funding information and opportunities. The company was founded in 1994 by James J. Marino, Jayne C. Gershkowitz, Abraham Abuchowski. The CEO is Debbie Hart. | Miscellaneous Commercial Services | Director/Board Member Chairman | |
| SOCIETAL CDMO, INC. | Pharmaceuticals: Major | Sales & Marketing | |
| MARIZYME, INC. | Biotechnology | Chief Executive Officer | |
| Chung-Ang University | College/University | Doctorate Degree | |
| 4D PHARMA PLC | Pharmaceuticals: Major | Director/Board Member | |
| ENTERO THERAPEUTICS, INC. | Biotechnology | Chief Executive Officer | |
Clinical Supplies Management, Inc.
 Clinical Supplies Management, Inc. Medical/Nursing ServicesHealth Services Clinical Supplies Management, Inc. engages in the provision of clinical trial supply solutions for pharmaceutical and biotechnology companies. Its clinical services include packaging and labeling; storage and global distribution; chain management consulting; and returns, reconciliation, and destruction. The company was founded by Gerald E. Finken in 1997 and is headquartered in Fargo, ND. | Medical/Nursing Services | Director/Board Member | |
| TOBIRA THERAPEUTICS INC | Pharmaceuticals: Major | Chief Executive Officer | |
| ORGAN ECO TECH CO.,LTD. | Medical Specialties | Director/Board Member | |
Leading Biosciences, Inc.
 Leading Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services Leading Biosciences, Inc. provides healthcare services. It offers therapy for severe sepsis, septic shock, and multi-organ failure. The company was founded by John Rodenrys and is headquartered in Carlsbad, CA. | Miscellaneous Commercial Services | Director/Board Member | |
| PDS BIOTECHNOLOGY CORPORATION | Pharmaceuticals: Major | Chairman Director/Board Member | |
Ambrx Biopharma, Inc.
 Ambrx Biopharma, Inc. BiotechnologyHealth Technology Ambrx Biopharma Cayman, Inc. operates as a clinical-stage biologics company. It focuses on discovering and developing a novel class of engineered precision biologics using its proprietary expanded genetic code technology platform that allows it to incorporate, in a site-specific manner, synthetic amino acids that do not exist in nature into proteins within living cells. The company was founded in January 2003 and is headquartered in La Jolla, CA. | Biotechnology | Chairman Founder Chairman | |
Blue Water Acquisition Corp. II
 Blue Water Acquisition Corp. II Financial ConglomeratesFinance Blue Water Acquisition Corp. II is a blank check company. It is formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The company was founded by Joseph Hernandez and is headquartered in Greenwich, CT. | Financial Conglomerates | Director/Board Member | |
Iqure Pharma, Inc.
 Iqure Pharma, Inc. Miscellaneous Commercial ServicesCommercial Services Iqure Pharma, Inc. is a biotech company that develops therapeutics for patients and physicians. The company is based in Wilmington, DE. The company was founded by Pawel Zolnierczyk, Henk de Wilde, Peter Schiemann, Anna Rzewuska. Pawel Zolnierczyk has been the CEO since incorporation. | Miscellaneous Commercial Services | Director/Board Member | |
| ONCONETIX, INC. | Chairman | ||
Ymmunobio AG
 Ymmunobio AG BiotechnologyHealth Technology Ymmunobio AG is a Swiss preclinical stage oncology biotech company that develops innovative treatments for cancer patients through new classes of antibodies. The company is based in Riehen, Switzerland. The company focuses on high unmet need indications in gastro-intestinal cancers, making extensive progress in developing first-in-class or novel class of antibodies that have the potential to overcome resistance of cancer patients to current available therapies. Ymmunobio's research is based on their deep understanding of immuno-oncology and precision cancer treatments, leveraging their profound knowledge of biologics while selecting the optimal approach to developing transformative therapeutics across cancer indications. The company was founded in 2021 by Katrin Rupalla. The CEO is Peter Schiemann. | Biotechnology | Founder |
Statistik
International
| Vereinigte Staaten | 35 |
| Südkorea | 7 |
| Vereinigtes Königreich | 3 |
| Schweiz | 3 |
| Dänemark | 2 |
Sektoral
| Health Technology | 30 |
| Consumer Services | 9 |
| Commercial Services | 6 |
| Finance | 3 |
| Distribution Services | 2 |
Operativ
| Director/Board Member | 61 |
| Corporate Officer/Principal | 35 |
| Independent Dir/Board Member | 22 |
| Chief Executive Officer | 20 |
| Chairman | 18 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| James Sapirstein | 26 |
| Daniel O'Connor | 22 |
| Stephen Glover | 19 |
| Gregory Freitag | 16 |
| Pablo Guzman | 13 |
| Katrin Rupalla | 13 |
| Nicholas LaBella | 10 |
| Robert Finizio | 10 |
| Karen Cashmere | 9 |
| Jeong-Wook Shin | 6 |
| Joo-Hyun Kim | 4 |
| Peter Wolfe | 3 |
- Börse
- Insiders
- Min-Chul Park
- Unternehmensverbindungen
